| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.089 | 0.1 |